IP Library Assignment 019290/0719
Patent Assignment
Reel/Frame 019290/0719

Assignment of Assignor's Interest

Recorded: 2007-05-14 Pages: 2
Assignors
YAN, SHUNQI
Executed: 2007-04-18
VERNIER, JEAN-MICHEL
Executed: 2007-04-18
HONG, ZHI
Executed: 2007-04-15
Assignee
ARDEA BIOSCIENCES
3300 HYLAND AVENUE, COSTA MESA, CALIFORNIA, 92626-1503
Covered Property (1)
N-Aryl-N'alkyl Sulfamides as Mek Inhibitors
Patent: 7,842,836 →
Application: 11/734,234 →
Publication: US 2007/0238710
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Jul 18, 2011
From: VALEANT PHARMACEUTICALS INTERNATIONAL, A DELAWARE CORPORATION; ATON PHARMA, INC., A DELAWARE CORPORATION; CORIA LABORATORIES, LTD., A DELAWARE CORPORATION; DOW PHARMACEUTICAL SCIENCES, INC., A DELAWARE CORPORATION
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 026606/0061 →
Corrective Partial Release of Security Interest in Patents Oct 12, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL; ATON PHARMA, INC.; CORIA LABORATORIES, LTD.; DOW PHARMACEUTICAL SCIENCES
Reel/Frame 027052/0883 →
Notice of Succession of Agency Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →